Winship clinicians and scientists will lead sessions and share their latest discoveries at the ASCO Annual Meeting in Chicago, June 2-6.
Winship Cancer Institute of Emory University clinicians and scientists will lead sessions and share their latest discoveries at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 2-6, 2023. This year's meeting will feature more than 2,900 research abstracts and 200 sessions, with a program focused on the theme "Partnering with Patients: The Cornerstone of Cancer Care and Research."
Founded in 1964, ASCO is the world's leading professional organization for physicians and oncology professionals caring for people with cancer. Its annual meeting brings together more than 40,000 oncology professionals from around the world to discuss the latest clinical cancer research impacting patient care.
Over the five-day meeting, more than 30 Winship presenters will describe new therapeutic targets and approaches; innovative tools to predict and improve treatment response; cancer prevention studies to understand and reduce the impact of hereditary, social and environmental risk factors; and research that aims to identify and mitigate demographic disparities in cancer care and outcomes.
Several Winship abstracts selected for oral presentation include new data from clinical trials of investigational cancer drugs, combination therapies and treatment strategies. Ajay Nooka, MD, MPH, professor of hematology and medical oncology, will report progress on two multiple myeloma trials: a phase 2 study of maintenance therapy with carfilzomib, pomalidomide and dexamethasone in high-risk patients; and a pooled analysis from the MagnetisMM studies evaluating the efficacy and safety of the drug elranatamab, which earlier this year was granted priority review by the Food and Drug Administration. Ticiana Leal, MD, associate professor of hematology and medical oncology, will present results from the randomized, phase 3 LUNAR study of Tumor Treating Field therapy with standard of care in metastatic non-small cell lung cancer following platinum failure. Tumor Treating Field therapy treats cancer using low-intensity electrical fields delivered through a wearable device. Leal’s abstract was also selected to be included in the 2023 Best of ASCO® program, which will be held later this summer.
Other Winship oral abstracts will address health services, outcomes and survivorship research, including the impact of insurance and financial status. Xu Ji, PhD, assistant professor of pediatrics, will report on Medicaid enrollment changes among U.S. adult survivors of childhood cancer following Medicaid expansion. Doctoral student Xin Hu, MSPH, will share research on the association of medical debt and cancer mortality in the U.S.
As part of the meeting, two Winship trainees have been honored with awards from Conquer Cancer, the ASCO Foundation. Doctoral student Ziyin Tang, MPH, received a Merit Award, which provides monetary support and complimentary meeting registration to present her first-author oral abstract, "Lung cancer metabolomics: A pooled analysis in the Cancer Prevention Studies." Hematology and medical oncology fellow Elizabeth Sakach, MD, received a Young Investigator Award, which provides funding to promising investigators to encourage and promote quality research in clinical oncology.
